Circulating Tumor Cell Market is Expected to Reach $5.9 Billion Globally by 2031 at a CAGR of 18.0%: Allied Market Research

Circulating Tumor Cell Market is Expected to Reach $5.9 Billion Globally by 2031 at a CAGR of 18.0%: Allied Market Research

RRising number of cancer cases, increased awareness of CTCs and their detection in cancer diagnosis, increase in research and development activities and increase in clinical trials are driving the growth of the global circulating tumor cell market .

PORTLAND, Oregon., December 9, 2022 /PRNewswire/ — Allied Market Research has released a report titled, ‚ÄúCirculating Tumor Cells Market By Technology (CTC Detection and Enrichment Method, CTC Direct Detection Methods, CTC Analysis), By Application (Clinical, Research), By End Users (Hospitals & Clinics, Diagnostic Centers, Others) : Global Opportunities Analysis and Industry Forecast, 2021-2031″. According to the report, the global circulating tumor cell industry generated $1.1 billion in 2021, and should generate $5.9 billion by 2031, with a CAGR of 18.0% from 2022 to 2031.

Allied Market Research (PRNewsfoto/Allied Market Research)

Allied Market Research (PRNewsfoto/Allied Market Research)

Download Free Sample Report – https://www.alliedmarketresearch.com/request-sample/12283

Main determinants of growth

Technological advances in the field of diagnosis and treatment, increase in the number of cancer cases, increased awareness of CTCs and their detection in cancer diagnosis, increase in research and development activities and increase of the number of clinical trials are driving the growth of the global circulating tumor cell market. However, the high cost associated with CTC testing due to high quality instruments used for testing is expected to hamper the market growth. Moreover, increasing investments by leading market players in developing countries, along with increasing adoption of various strategies by leading players, are expected to present new opportunities in the coming years.

Covid-19 scenario

  • The outbreak of the COVID-19 pandemic has disrupted healthcare workflows globally. COVID-19 has forced a number of industries, including several healthcare subfields, to temporarily shut down.

  • The global circulating tumor cell industry witnessed a decline in sales in 2020, owing to the global economic recession in 2020.

  • Additionally, there has been a decrease in the number of patient visits to hospitals for treatment of illnesses other than COVID-19, which has also reduced the number of tests performed for cancer diagnosis and CTC detection. . This factor has also decreased the sale of products and instruments related to CTC testing during the pandemic.

  • However, the market has seen a recovery in 2021 and is expected to show stable post-pandemic growth. This growth is attributed to the increase in the number of patient visits to hospitals after the pandemic and the increase in the number of diagnostic centers.

The CTC Detection and Enrichment Methods segment to maintain its leading status throughout the forecast period

Based on technology, the CTC detection and enrichment methods segment held the highest market share in 2021, accounting for nearly three-fifths of the global circulating tumor cell market, and is expected to maintain its leading status throughout the forecast period. This is due to the advantages this method offers over direct detection, such as rapid test results, high purity of cell detection, quick and easy cell isolation techniques such as immunocapture. However, the CTC analysis segment is expected to show the highest CAGR of 19.0% from 2022 to 2031, due to increased developments in this segment, such as the use of FISH and RT PCR techniques for CTC detection and cancer diagnosis.

The clinic segment to maintain its leading status throughout the forecast period

Based on applications, the clinical segment held the highest market share in 2021, accounting for more than two-thirds of the global circulating tumor cell market, and is expected to maintain its leading status throughout the forecast period. This is due to the increase in the adoption of CTC detection techniques in cancer diagnosis as well as an increase in the number of cancer cases including breast, prostate and colon cancer. However, the research segment is expected to show the highest CAGR of 18.6% from 2022 to 2031, owing to an increase in research and development activities in cancer detection and diagnosis by CTC.

For Purchase Inquiry – https://www.alliedmarketresearch.com/purchase-enquiry/12283

diagnostic centers segment to maintain its leading position during the forecast period

Based on end-users, diagnostic center segment accounted for the largest share in 2021, contributing more than half of the global circulating tumor cell market, and is expected to maintain its leading position during the forecast period. This is due to the large number of patient visits to diagnostic centers after the COVID-19 pandemic, as they offer accurate tests and help healthcare providers decide on the treatment regimen. The report also discusses segments including Hospitals & Clinics, and Others. However, the others segment would reach the fastest CAGR of 18.5% through 2031, due to the increase in funding offered to research centers and academic research institutes by governmental and non-governmental organizations.

North America maintain dominance by 2031

Based on the region, North America held the highest market share by revenue in 2021, accounting for more than two-fifths of the global circulating tumor cell market, and is expected to dominate the market over the forecast period, driven by well-developed healthcare infrastructure established and favorable policies offered by the government for the diagnosis and treatment of cancer. However, the Asia Pacific The region is expected to witness the fastest CAGR of 20.2% from 2022 to 2031, owing to the presence of pharmaceutical companies in the region as well as the growing purchasing power of populated countries, such as China, Japan and India.

Major Market Players:-

  • Miltenyi Biotec

  • Precision Medicine Group LLC

  • Menarini Group

  • SRI International

  • Biocept, Inc.

  • QIAGEN

  • Greiner AG

  • Sysmex Company

  • Thermo Fisher Scientific Inc.

  • STEMCELL Technologies Inc.

Health Industry Trend Reports-

Pharmaceutical Suppositories Market – Global Opportunity Analysis and Industry Forecast, 2020-2030

Orthopedic Implants Market – Global Opportunity Analysis and Industry Forecast, 2020-2030

Human DNA Vaccine Market Potential Analysis – Global Opportunity Analysis and Industry Forecast, 2020-2030

3D Printed Drugs Market – Global Opportunity Analysis and Industry Forecast, 2020-2030

Wearable Injectors Market – Global Opportunity Analysis and Industry Forecast, 2020-2030

Computed Tomography (CT) Market – Global Opportunity Analysis and Industry Forecast, 2020-2030

Empty Capsules Market – Global Opportunity Analysis and Industry Forecast, 2020-2030

AVENUE – A subscription library (Premium on demand, subscription pricing model) Offered by Allied Market Research:

AMR introduces its subscription-based premium online library Avenue, designed specifically to provide a unique and cost-effective solution for businesses, investors and universities. With Avenue, subscribers can benefit from a comprehensive repository of reports on over 2,000 niche industries and over 12,000 company profiles. Additionally, users can get online access to quantitative and qualitative data in PDF and Excel formats, as well as analyst support, customization, and updated versions of reports.

Access the report library anytime from any device and anywhere. For more details, follow the link: https://www.alliedmarketresearch.com/library-access

“We have also published some syndicated market studies in the same field that you may be interested in. Below is the title of the report for your referenceconsidering the impact of Covid-19 on this market which will help you to assess the aftereffects of the pandemic on the short and long term growth trends of this market.”

About Allied Market Research:

Allied Market Research (AMR) is a full-service market research and business advisory division of Allied Analytics LLP based in Portland, OR. Allied Market Research provides global corporations as well as small and medium enterprises with unrivaled quality of “market research reports” and “Business Intelligence solutions”. AMR has a focused vision to provide business insights and advice to help its clients make strategic business decisions and achieve sustainable growth in their respective market areas. AMR offers its services across 11 verticals, including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverage, Energy & Power, semiconductors and electronics, automotive and transport, ICT and media, aerospace and defense and BFSI.

We maintain professional relationships with various companies which helps us to extract market data which helps us to generate accurate research data tables and confirm the utmost accuracy of our market predictions. CEO of Allied Market Research Pawan Kumar is essential to inspire and encourage everyone associated with the business to maintain high quality data and help customers in every way possible to achieve success. All data presented in the reports we publish are drawn from primary interviews with senior managers of large companies in the relevant field. Our secondary data sourcing methodology includes extensive online and offline research and discussions with knowledgeable industry professionals and analysts.

Contact
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
hong kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
Follow us on: LinkedIn Twitter

Logo: https://mma.prnewswire.com/media/636519/Allied_Market_Research_Logo.jpg

Quote

Quote

View original content for multimedia download: https://www.prnewswire.com/news-releases/circulating-tumor-cell-market-predicted-to-reach-usd-5-9-billion-globally-by-2031 -at-18-0-cagr-allied-market-research-301699012.html

SOURCE Allied Market Research


#Circulating #Tumor #Cell #Market #Expected #Reach #Billion #Globally #CAGR #Allied #Market #Research

Leave a Comment

Your email address will not be published. Required fields are marked *